\BOOKMARK [0][-]{chapter*.1}{Abstract}{}% 1
\BOOKMARK [0][-]{chapter*.2}{Preface}{}% 2
\BOOKMARK [0][-]{chapter*.3}{Table of Contents}{}% 3
\BOOKMARK [0][-]{chapter*.4}{List of Tables}{}% 4
\BOOKMARK [0][-]{chapter*.5}{List of Figures}{}% 5
\BOOKMARK [0][-]{chapter*.6}{Glossary}{}% 6
\BOOKMARK [0][-]{chapter*.7}{Acknowledgments}{}% 7
\BOOKMARK [0][-]{chapter.1}{1 Introduction}{}% 8
\BOOKMARK [1][-]{section.1.1}{1.1 Objectives}{chapter.1}% 9
\BOOKMARK [1][-]{section.1.2}{1.2 Pharmacogenomics in Clinical Oncology}{chapter.1}% 10
\BOOKMARK [1][-]{section.1.3}{1.3 The Evolution of Next-Generation Sequencing}{chapter.1}% 11
\BOOKMARK [1][-]{section.1.4}{1.4 Bioinformatics Tools for Variant Calling}{chapter.1}% 12
\BOOKMARK [2][-]{subsection.1.4.1}{1.4.1 Types of Genomic Alterations}{section.1.4}% 13
\BOOKMARK [2][-]{subsection.1.4.2}{1.4.2 Variant Calling Pipelines}{section.1.4}% 14
\BOOKMARK [2][-]{subsection.1.4.3}{1.4.3 Variant Calling Algorithms}{section.1.4}% 15
\BOOKMARK [1][-]{section.1.5}{1.5 Challenges in Clinical Next-Generation Sequencing Testing}{chapter.1}% 16
\BOOKMARK [2][-]{subsection.1.5.1}{1.5.1 Formalin Artifacts in DNA}{section.1.5}% 17
\BOOKMARK [2][-]{subsection.1.5.2}{1.5.2 Tumour-only Profiling}{section.1.5}% 18
\BOOKMARK [1][-]{section.1.6}{1.6 Summary}{chapter.1}% 19
\BOOKMARK [0][-]{chapter.2}{2 Variant Calling in Formalin-fixed Paraffin-embedded Tumours}{}% 20
\BOOKMARK [1][-]{section.2.1}{2.1 Overview}{chapter.2}% 21
\BOOKMARK [0][-]{chapter*.8}{Bibliography}{}% 22
\BOOKMARK [0][-]{appendix.A}{A Supporting Materials}{}% 23
